N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2
Abstract Background Elevated evidence suggests that the SENPs family plays an important role in tumor progression. However, the role of SENPs in AML remains unclear. Methods We evaluated the expression pattern of SENP1 based on RNA sequencing data obtained from OHSU, TCGA, TARGET, and MILE datasets....
保存先:
| 主要な著者: | , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2024-05-01
|
| シリーズ: | Molecular Cancer |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s12943-024-02013-y |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|